Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support

需要体外呼吸支持的 COVID-19 患者的死亡风险因素

阅读：1
作者：Riera,Jordi,Alcántara,Sara,Bonilla,Camilo,Fortuna,Phillip,Blandino Ortiz,Aaron,Vaz,Ana,Albacete,Carlos,Millán,Pablo,Ricart,Pilar,Boado,María Victoria,Ruiz de Gopegui,Pablo,Santa Teresa,Patricia,Sandoval,Elena,Pérez-Chomón,Helena,González-Pérez,Alfredo,Duerto,Jorge,Gimeno,Ricardo,Colomina,Joaquín,Gómez,Vanesa,Renedo,Gloria,Naranjo,José,García,Manuel Alfonso,Rodríguez-Ruiz,Emilio,Silva,Pedro Eduardo,Pérez,Daniel,Veganzones,Javier,Voces,Roberto,Martínez,Sergi,Blanco-Schweizer,Pablo,García,Marta,Villanueva-Fernández,Héctor,Fuset,María Paz,Luna,Stephani María,Martínez-Martínez,María,Argudo,Eduard,Chiscano,Luis,Roncon-Albuquerque,Roberto Jr
期刊：European Respiratory Journal影响因子：21.000
时间：2022起止号：2022 Feb;59(2)
doi：10.1183/13993003.02463-2021

Abstract

When indicating ECMO in patients with COVID-19, centre case volume, age, driving pressure and the duration of symptoms (not the length of MV) should be taken into account. Large drainage cannula and high PEEP levels during the first days are recommended. https://bit.ly/3DGjGkk

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。

2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。

4、投稿及合作请联系：info@biocloudy.com。